[Prognosis of rectal carcinoma treated initially with 60Cobalt gamma and ultrahigh betatron roentgen irradiation].
D000230:Adenocarcinoma / Q000175:diagnosis / Q000532:radiotherapy*; D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000532:radiotherapy*; D003036:Cobalt Isotopes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D012004:Rectal Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*
D003036:Cobalt Isotopes
Die Prognose des Rektumkarzinoms bei primärer Behandlung mit Kobalt-60-Gamma-und ultraharten Röntgenstrahlen des Betatrons.